19 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Medical management of Stable Ischemic Heart Disease

#Management #Cardiology #Medical #Treatment #Stable #Ischemic #HeartDisease #Algorithm
Medical management ... of Stable Ischemic ... #Management #Cardiology ... #Medical #Treatment ... #HeartDisease #Algorithm
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Managing BPD Clinical ... with ‘treatment ... summarised in Tables ... EBM #Management #Pharmacology ... Effectiveness #Table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
stimulation and mental ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... • TB expert medical ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
fatigue, altered mental ... #differential #algorithm ... #management #cardiology ... #treatment #table ... #pharmacology
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Clinical • Under-recognized ... Delivery • Stable ... deteriorating on medical ... diagnosis #management #cardiology ... #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology